368 related articles for article (PubMed ID: 20668086)
1. A multivalent vaccination strategy for the prevention of Old World arenavirus infection in humans.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Kotturi MF; Sette A; Buchmeier MJ
J Virol; 2010 Oct; 84(19):9947-56. PubMed ID: 20668086
[TBL] [Abstract][Full Text] [Related]
2. A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease.
Kotturi MF; Botten J; Sidney J; Bui HH; Giancola L; Maybeno M; Babin J; Oseroff C; Pasquetto V; Greenbaum JA; Peters B; Ting J; Do D; Vang L; Alexander J; Grey H; Buchmeier MJ; Sette A
PLoS Pathog; 2009 Dec; 5(12):e1000695. PubMed ID: 20019801
[TBL] [Abstract][Full Text] [Related]
3. HLA-A2-restricted protection against lethal lymphocytic choriomeningitis.
Botten J; Whitton JL; Barrowman P; Sidney J; Whitmire JK; Alexander J; Ting JP; Bui HH; Sette A; Buchmeier MJ
J Virol; 2007 Mar; 81(5):2307-17. PubMed ID: 17166907
[TBL] [Abstract][Full Text] [Related]
4. Identification of protective Lassa virus epitopes that are restricted by HLA-A2.
Botten J; Alexander J; Pasquetto V; Sidney J; Barrowman P; Ting J; Peters B; Southwood S; Stewart B; Rodriguez-Carreno MP; Mothe B; Whitton JL; Sette A; Buchmeier MJ
J Virol; 2006 Sep; 80(17):8351-61. PubMed ID: 16912286
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the Glycoprotein GP2 Subunit Cross-React between Old and New World Arenaviruses.
Amanat F; Duehr J; Oestereich L; Hastie KM; Ollmann Saphire E; Krammer F
mSphere; 2018; 3(3):. PubMed ID: 29720525
[TBL] [Abstract][Full Text] [Related]
6. Highly Pathogenic New World Arenavirus Infection Activates the Pattern Recognition Receptor Protein Kinase R without Attenuating Virus Replication in Human Cells.
Huang C; Kolokoltsova OA; Mateer EJ; Koma T; Paessler S
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794024
[TBL] [Abstract][Full Text] [Related]
7. Lassa Virus, but Not Highly Pathogenic New World Arenaviruses, Restricts Immunostimulatory Double-Stranded RNA Accumulation during Infection.
Mateer EJ; Maruyama J; Card GE; Paessler S; Huang C
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051278
[TBL] [Abstract][Full Text] [Related]
8. Residues K465 and G467 within the Cytoplasmic Domain of GP2 Play a Critical Role in the Persistence of Lymphocytic Choriomeningitis Virus in Mice.
Iwasaki M; Ng CT; Cubitt B; de la Torre JC
J Virol; 2016 Nov; 90(22):10102-10112. PubMed ID: 27581982
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein-Specific Antibodies Produced by DNA Vaccination Protect Guinea Pigs from Lethal Argentine and Venezuelan Hemorrhagic Fever.
Golden JW; Maes P; Kwilas SA; Ballantyne J; Hooper JW
J Virol; 2016 Jan; 90(7):3515-29. PubMed ID: 26792737
[TBL] [Abstract][Full Text] [Related]
10. Highly Pathogenic New World and Old World Human Arenaviruses Induce Distinct Interferon Responses in Human Cells.
Huang C; Kolokoltsova OA; Yun NE; Seregin AV; Ronca S; Koma T; Paessler S
J Virol; 2015 Jul; 89(14):7079-88. PubMed ID: 25926656
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
[TBL] [Abstract][Full Text] [Related]
12. The High Degree of Sequence Plasticity of the Arenavirus Noncoding Intergenic Region (IGR) Enables the Use of a Nonviral Universal Synthetic IGR To Attenuate Arenaviruses.
Iwasaki M; Cubitt B; Sullivan BM; de la Torre JC
J Virol; 2016 Jan; 90(6):3187-97. PubMed ID: 26739049
[TBL] [Abstract][Full Text] [Related]
13. Arenavirus Genome Rearrangement for the Development of Live Attenuated Vaccines.
Cheng BY; Ortiz-Riaño E; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Jul; 89(14):7373-84. PubMed ID: 25972555
[TBL] [Abstract][Full Text] [Related]
14. Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.
Rojek JM; Sanchez AB; Nguyen NT; de la Torre JC; Kunz S
J Virol; 2008 Aug; 82(15):7677-87. PubMed ID: 18508885
[TBL] [Abstract][Full Text] [Related]
15. An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice.
Hashizume M; Takashima A; Iwasaki M
J Virol; 2024 Jun; 98(6):e0057824. PubMed ID: 38767352
[TBL] [Abstract][Full Text] [Related]
16. Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.
Brouillette RB; Phillips EK; Ayithan N; Maury W
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100617
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.
de la Torre JC
Ann N Y Acad Sci; 2009 Sep; 1171 Suppl 1():E57-64. PubMed ID: 19751403
[TBL] [Abstract][Full Text] [Related]
18. A Vaccine Platform against Arenaviruses Based on a Recombinant Hyperattenuated Mopeia Virus Expressing Heterologous Glycoproteins.
Carnec X; Mateo M; Page A; Reynard S; Hortion J; Picard C; Yekwa E; Barrot L; Barron S; Vallve A; Raoul H; Carbonnelle C; Ferron F; Baize S
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593043
[TBL] [Abstract][Full Text] [Related]
19. Machupo Virus with Mutations in the Transmembrane Domain and Glycosylation Sites of the Glycoprotein Is Attenuated and Immunogenic in Animal Models of Bolivian Hemorrhagic Fever.
Mantlo EK; Maruyama J; Manning JT; Wanninger TG; Huang C; Smith JN; Patterson M; Paessler S; Koma T
J Virol; 2022 Apr; 96(8):e0020922. PubMed ID: 35343792
[TBL] [Abstract][Full Text] [Related]
20. Development of live-attenuated arenavirus vaccines based on codon deoptimization.
Cheng BY; Ortiz-Riaño E; Nogales A; de la Torre JC; Martínez-Sobrido L
J Virol; 2015 Apr; 89(7):3523-33. PubMed ID: 25589652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
